Abbvie Header week 48

Abbvie Header week 48

X

Digital content for Diverchim S.A.

Diverchim S.A.

DIVERCHIM S.A.

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

VIDEO(s)

VIDEO

VIDEO

DIGITAL CONTENT

2 News

2 News

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

SERVICES

All Services, API Manufacturing, Analytical, API & Drug Product Development

All Services
API Manufacturing
Analytical
- 3 Analytical Testing Services
- 3 Analytical Method Development
API & Drug Product Development
- 3 Preformulation & Material Science
- 9 API Development

INSPECTIONS & REGISTRATIONS

2 EDQM

2 EDQM

Full View Screen

Full Screen View

NFL BIOSCIENCES: agreement signed with Diverchim to manufacture

NFL BIOSCIENCES: agreement signed with Diverchim to manufacture

GLOBENEWSWIRE

17 Nov 2021

Diverchim Activities Are Takeover By Group of Investors

Diverchim Activities Are Takeover By Group of Investors

PRESS RELEASE

01 Aug 2017

pfizer-centreone-m-2022-12-05

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search